A recent spate of awards shines a light on the strides UTHSC researchers are making in translating their discoveries into novel solutions for human health and well-being. Three licensees, two spinoffs founded by UTHSC researchers and one long-standing partner, have received funding from the highly competitive Small Business Innovation Research (SBIR) and Small Business Technology… Read More
UTHSC researchers working to find new treatments to combat breast cancer metastasis recently pulled in a major national award. Wei Li, PhD, distinguished professor of Pharmaceutical Sciences and director of the Drug Discovery Center in the College of Pharmacy, and Tiffany Seagroves, PhD, professor of Pathology in the College of Medicine, are principal investigators on… Read More
A team of UTHSC researchers has been awarded $924,000 from the Department of Defense for their work developing a new treatment for ovarian cancer. The project is a collaboration between the labs of Wei Li, PhD, distinguished professor of Pharmaceutical Sciences and director of the Drug Discovery Center in the College of Pharmacy, Junming Yue,… Read More
A research project that could expand the treatment options for epilepsy has received significant federal funding. Jianxiong Jiang, PhD, associate professor in Pharmaceutical Sciences and Neurobiology at the University of Tennessee Health Science Center, and Wei Li, PhD, Distinguished Professor and director of the UTHSC College of Pharmacy Drug Discovery Center, were recently awarded $1.15 million… Read More
Wei Li, PhD, professor in the Department of Pharmaceutical Sciences in the University of Tennessee Health Science Center’s College of Pharmacy, has been appointed a UTHSC Distinguished Professor. The title is reserved for those who have contributed in a superlative way to UTHSC and brought distinction and respect to the university. The appointment comes from… Read More
A research team at the University of Tennessee Health Science Center has been awarded $2.27 million to study a potential next-generation treatment for late-stage breast cancer. Wei Li, PhD, professor of Pharmaceutical Sciences and director of the UTHSC College of Pharmacy Drug Discovery Center, and Tiffany Seagroves, PhD, professor of Pathology in the UTHSC College… Read More
